Ursamin, Inc.
StreetZero Signal 55
About Ursamin, Inc.
Ursamin, Inc. provides a SaaS care coordination platform for primary care providers, specialists, caregivers, and patients focused on managing multiple chronic illnesses. The platform aims to simplify workflows, improve data accuracy, and enhance healthcare outcomes through collaboration. Founded in 2021 and headquartered in Fayetteville, New York, the company launched its platform and formed an advisory board to support its efforts. It has been selected for accelerators including Fulcrum Venture Accelerator and Twende Accelerator.
LATEST FUNDINGPrivate Placement
$125K
Announced 2026-11-10
TOTAL RAISED$555K
IN THE NEWS
EMPLOYEES11-50
FOUNDED2021
HQFayetteville, New York, United States
Industry
Other Technology
Tags
HealthcareSaaSCare CoordinationChronic Illness
Key highlights
- Raised $500K Seed round in May 2023 and $55K Convertible Note in 2025.
- Platform targets management of multiple chronic conditions via collaborative SaaS tools.
- Selected for Fulcrum Venture Accelerator fifth cohort and Twende Accelerator.
- Announced live platform launch and formation of advisory board in 2024.
- Headquartered in Fayetteville, NY with 21 employees and focus on primary care workflows.
Ask StreetZero about Ursamin, Inc.
Put our AI to work on this deal.
Similar companies
Other Other Technology deals, ranked by Signal.
Source document & SEC filing
The source SEC filing and the cached document are available to members only. Sign in to view and download them.
Sign in to view the filing Create free account